Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-20

FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lisinopril (Actavis Pharma, Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)